Mirum Pharmaceuticals, Inc. (MIRM)
90.17
-2.12
(-2.30%)
USD |
NASDAQ |
Mar 02, 16:00
90.17
0.00 (0.00%)
After-Hours: 19:05
Mirum Pharmaceuticals EPS Diluted (Quarterly) : -0.111 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| BridgeBio Pharma, Inc. | -0.9964 |
| XOMA Royalty Corp. | 0.6991 |
| CorMedix, Inc. | 1.259 |
| ADMA Biologics, Inc. | 0.2025 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.73M |
| Revenue (Quarterly) | 148.93M |
| Total Expenses (Quarterly) | 154.66M |
| Enterprise Value | 4.679B |
| Gross Profit Margin (Quarterly) | 80.97% |
| Profit Margin (Quarterly) | -3.85% |
| Earnings Yield | -0.53% |
| Normalized Earnings Yield | -0.5302 |